glp 1 agonists for alcohol use disorder GLP-1 receptor are promising but unproven treatments and substance disorders Searching for New Pharmacological Treatments

Lancet (2016) 388(10053):1659724

Vidal-Casariego 2013 meta-analysis: Four RCTs with 284 type 2 diabetes patients showed 23 g/day L-carnitine for 1252 weeks reduced fasting glucose, total cholesterol, LDL cholesterol, and apolipoproteins B100 and A1 but NOT triglycerides, lipoprotein(a), or HbA1c [3][43]

Each format has trade-offs in absorption and handling for research

Indication: Infused with N-Acetyl L-Cysteine or NAC that is known to be essential for making an antioxidant glutathione

I do think there's a lack of really good solid evidence in humans, but that might only be because it's just not studied enough, and that's usually the case